Key facts
- This page summarizes David Hung's Form 4 filing for Nuvation Bio Inc. (NUVB).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 04 Mar 2025, 18:33.
David Hung - 28 Feb 2025 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)
- Issuer symbol
- NUVB
- Report date
- 28 Feb 2025
- Net transaction value
- $0
- Form type
- 4
- Accepted by SEC
- 04 Mar 2025, 18:33:16 UTC
- Previous filing
- 06 Jun 2024
- Next filing
- 08 Apr 2025
- SEC filing
- View on sec.gov
- Reporting owner signature
- /s/ Ron A. Metzger, Attorney-in-Fact
Source evidence
5 source fields
Reporting owner
1 detail
Key filing fact
David Hung filed Form 4 for Nuvation Bio Inc. (NUVB) on 04 Mar 2025.
Change
- Previous filing in this sequence was filed on 06 Jun 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NUVB
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +2,000,000
- Change %
- Price
- $0.000000
- Shares after
- 2,000,000
- Date
- 28 Feb 2025
- Ownership
- Direct
- Underlying class
- Class B Common Stock
- Underlying amount
- 2,000,000
- Exercise price
- $1.97
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Option vests as to 25% on the one year anniversary of 2/28/2025, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.